110 related articles for article (PubMed ID: 15768446)
21. Trends in the use of oral antidiabetic drugs by outpatients in Taiwan: 1997-2003.
Chiang CW; Chiu HF; Chen CY; Wu HL; Yang CY
J Clin Pharm Ther; 2006 Feb; 31(1):73-82. PubMed ID: 16476123
[TBL] [Abstract][Full Text] [Related]
22. A review on the actual trends of insulin treatment in elderly with diabetes.
Motta M; Bennati E; Ferlito L; Passamonte M; Cardillo E; Malaguarnera M
Arch Gerontol Geriatr; 2008; 47(1):151-61. PubMed ID: 17913262
[TBL] [Abstract][Full Text] [Related]
23. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
Habib SS; Aslam M; Naveed AK; Razi MS
Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
[TBL] [Abstract][Full Text] [Related]
24. Regional and international comparison in utilization of antidiabetic drugs.
Stanulović M; Jakovljević V; Kovac T; Lepsanović L; Ducić M
Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):254-6. PubMed ID: 3525425
[TBL] [Abstract][Full Text] [Related]
25. Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVE study.
Dornhorst A; Lüddeke HJ; Sreenan S; Kozlovski P; Hansen JB; Looij BJ; Meneghini L;
Int J Clin Pract; 2008 Apr; 62(4):659-65. PubMed ID: 18324957
[TBL] [Abstract][Full Text] [Related]
26. Variation in antidiabetic medication intensity among Medicare beneficiaries with diabetes mellitus.
Stuart B; Shaffer TJ; Simoni-Wastila LJ; Zuckerman IH; Quinn CC
Am J Geriatr Pharmacother; 2007 Sep; 5(3):195-208. PubMed ID: 17996659
[TBL] [Abstract][Full Text] [Related]
27. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study.
Valensi P; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Wenying Y;
Int J Clin Pract; 2009 Mar; 63(3):522-31. PubMed ID: 19187170
[TBL] [Abstract][Full Text] [Related]
28. Trends in the use of lipid-lowering drugs by outpatients with diabetes in Taiwan, 1997-2003.
Chiang CW; Chiu HF; Chen CY; Wu HL; Yang CY
Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):62-9. PubMed ID: 17924453
[TBL] [Abstract][Full Text] [Related]
29. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
Fabian W; Majkowska L; Stefański A; Moleda P
Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
[TBL] [Abstract][Full Text] [Related]
30. Unlocking the opportunity of tight glycaemic control. Far from goal.
Del Prato S
Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S1-4. PubMed ID: 16135133
[TBL] [Abstract][Full Text] [Related]
31. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
von Ferber L; Köster I; Hauner H
Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
[TBL] [Abstract][Full Text] [Related]
32. A longitudinal observational study of insulin therapy and glycaemic control in Scottish children with Type 1 diabetes: DIABAUD 3.
Scottish Study Group for the Care of the Young with Diabetes
Diabet Med; 2006 Nov; 23(11):1216-21. PubMed ID: 17054598
[TBL] [Abstract][Full Text] [Related]
33. [Trends in prescribing oral antidiabetic drugs. An analysis of the Berlin diabetes register covering 28 years].
Ratzmann KP; Thoelk H
Med Klin (Munich); 1992 Jan; 87(1):8-11. PubMed ID: 1545772
[TBL] [Abstract][Full Text] [Related]
34. Drug sales data and prevalence of diabetes in France.
Fontbonne A; Papoz L; Eschwege E
Rev Epidemiol Sante Publique; 1986; 34(2):100-5. PubMed ID: 3738066
[TBL] [Abstract][Full Text] [Related]
35. [Epidemiology of diabetes in metropolitan France].
Ricordeau P; Weill A; Vallier N; Bourrel R; Fender P; Allemand H
Diabetes Metab; 2000 Sep; 26 Suppl 6():11-24. PubMed ID: 11011236
[TBL] [Abstract][Full Text] [Related]
36. Trends in oral antihyperglycemic and insulin use in the Nova Scotia senior population (1993-1999).
Morningstar BA; Sketris IS; Kephart GC; Sclar DA
Can J Clin Pharmacol; 2002; 9(3):123-9. PubMed ID: 12422249
[TBL] [Abstract][Full Text] [Related]
37. [Drug consumption in diabetes mellitus (III). Trends of hypoglycemic agents use and consumption in Tarragona, Catalonia, and Spain (1988- 1991). Group for the Study of Diabetes in Tarragona].
Costa B; Hernández JM
Med Clin (Barc); 1993 Apr; 100(15):571-5. PubMed ID: 8497145
[TBL] [Abstract][Full Text] [Related]
38. Nurse prescribing in diabetes.
Cradock S; Avery L
Prof Nurse; 1998 Feb; 13(5):315-7, 319. PubMed ID: 9544084
[TBL] [Abstract][Full Text] [Related]
39. Determinants of prescribing patterns for type II diabetes at Primary Care Trust level.
Lloyd DC; Scrivener G
J Clin Pharm Ther; 2004 Aug; 29(4):389-94. PubMed ID: 15271107
[TBL] [Abstract][Full Text] [Related]
40. Estimation of the prevalence of diabetes mellitus in Israel based on hypoglycemic drug supply and consumption.
Cohen R; Fontbonne A; Weitzman S; Eschwege E
Diabete Metab; 1990; 16(2):59-63. PubMed ID: 2369973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
